Drug – bio-affecting and body treating compositions – Antigen – epitope – or other immunospecific immunoeffector – Virus or component thereof
Reexamination Certificate
2005-08-18
2008-05-27
Salimi, Ali R. (Department: 1648)
Drug, bio-affecting and body treating compositions
Antigen, epitope, or other immunospecific immunoeffector
Virus or component thereof
C435S006120
Reexamination Certificate
active
07378100
ABSTRACT:
A fusion protein for inhibiting cervical cancer is disclosed, which comprises a peptide sequence of human papillomavirus type 16, a peptide translocating peptide for translocation, and a peptide within a carboxyl terminal fragment. The present invention further comprising a composition of antibody, which conjugates to E7 peptide, wherein the nucleotide sequence corresponding to the amino acid sequence of the E7 peptide is shown as SEQ. ID. NO.1.
REFERENCES:
patent: 5705163 (1998-01-01), Pastan et al.
patent: 6214541 (2001-04-01), Zentgraf et al.
patent: 2004/0086845 (2004-05-01), Wu et al.
patent: 2004/0247617 (2004-12-01), Liao et al.
patent: WO 03/080669 (2003-10-01), None
patent: WO 03/085085 (2003-10-01), None
Hung et al. Cancer Research, May 2001, vol. 61, pp. 3698-3703.
Y.Qin, et al. “Human papillomavirus type 16 E7 peptide38-61 linked with an immunoglobulin G fragment provides protective immunity in mice”, Gynecologic Oncology, 2005, vol. 96, pp. 475-483.
C. Liao, et al., “Fusion Protein Vaccine by Domains of Bacterial Exotoxin Linked with a Tumor Antigen Generates Potent Immunologic Responses and Antitumor Effects”, Cancer Res, 2005, vol. 65, No. 19, pp. 9089-9098.
Chang Hsui-Kang
Cheng Wen-Fang
Liao Chao-We
Bacon & Thomas PLLC
Healthbanks Biotech Co., Ltd.
Salimi Ali R.
LandOfFree
Fusion protein for inhibiting cervical cancer does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Fusion protein for inhibiting cervical cancer, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Fusion protein for inhibiting cervical cancer will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3986151